cjc1295 & ipamorelin Blog CJC1295/Ipamorelin (No DAC) - Apollo

One unit on a 1 ml insulin syringe always equals 0.02 mg of Tesamorelin or Ipamorelin, regardless of vial size

As a synthetic growth hormone-releasing peptide, IGF-1 LR3 is renowned for its ability to promote anabolic muscle cell signaling and extend the half-life of growth factor analogs

(2) CJC-1295 clinical trial data showing GHRH-R-mediated GH/IGF-1 elevation (Teichman et al

These findings suggest that doses of CJC-1295 DAC and CJC-1295 Ipamorelin should be limited to 2,000 g per week, regardless of an individual test subjects body weight

And in the context of GH biology, overshooting carries consequences: IGF-1 excess has associations with insulin resistance, fluid retention, and in some populations, oncological risk